spacer
spacer

Jump to: InterProScan Databases Documentation FTP site Help Advanced search

InterPro: IPR000608 Ubiquitin-conjugating enzyme, E2

Protein matchesHelp
UniProtKB
Matches:
4499 proteins
AccessionHelp IPR000608 UBQ-conjugat_E2
SecondaryHelp IPR015579
TypeHelp Domain
SignaturesHelp
InterPro RelationshipsHelp
Parent IPR016135 Ubiquitin-conjugating enzyme/RWD-like
Found in IPR008883 Tumour susceptibility gene 101
IPR015580 RUB1 conjugating enzyme Ubc12
IPR015581 Ubiquitin-conjugating enzyme
IPR015582 Ubiquitin-conjugating enzyme E2 H10
GO Term annotationHelp
Process GO:0043687 post-translational protein modification
GO:0051246 regulation of protein metabolic process
Function GO:0019787 small conjugating protein ligase activity
InterPro annotation
BioMart Logo Entry Details in BioMart
AbstractHelp

The post-translational attachment of ubiquitin (IPR000626) to proteins (ubiquitinylation) alters the function, location or trafficking of a protein, or targets it to the 26S proteasome for degradation [1, 2, 3]. Ubiquitinylation is an ATP-dependent process that involves the action of at least three enzymes: a ubiquitin-activating enzyme (E1, IPR000011), a ubiquitin-conjugating enzyme (E2), and a ubiquitin ligase (E3, IPR000569, IPR003613), which work sequentially in a cascade [4]. The E1 enzyme mediates an ATP-dependent transfer of a thioester-linked ubiquitin molecule to a cysteine residue on the E2 enzyme. The E2 enzyme (EC:6.3.2.19) then either transfers the ubiquitin moiety directly to a substrate, or to an E3 ligase, which can also ubiquitinylate a substrate.

There are several different E2 enzymes (over 30 in humans), which are broadly grouped into four classes, all of which have a core catalytic domain (containing the active site cysteine), and some of which have short N- and C-terminal amino acid extensions: class I enzymes consist of just the catalytic core domain (UBC), class II possess a UBC and a C-terminal extension, class III possess a UBC and an N-terminal extension, and class IV possess a UBC and both N- and C-terminal extensions. These extensions appear to be important for some subfamily function, including E2 localisation and protein-protein interactions [5]. In addition, there are proteins with an E2-like fold that are devoid of catalytic activity, but which appear to assist in poly-ubiquitin chain formation.

Structural linksHelp
PDB - click here
SCOP: d.20.1.1 , d.20.1.2
CATH: 3.10.110.10
Database linksHelp
PDBe-motif: PS00183
PROSITE doc: PDOC00163
PANDIT: PF00179
Blocks: IPB000608
Pfam Clan: CL0208.7

Taxonomic coverageHelp

Overlapping InterPro entriesHelp
IPR000608 Numbers of overlapping proteins Average numbers of overlapping amino acids

Example proteinsHelp
A1ZBR5 Protein crossbronx-like

O00762 Ubiquitin-conjugating enzyme E2 C

P06104 Ubiquitin-conjugating enzyme E2 2

P34477 Probable ubiquitin-conjugating enzyme E2 7

P60605 Ubiquitin-conjugating enzyme E2 G2

More proteins


Example Proteins Key


InterPro entry accession number/name and structure databases Colour code
IPR016135 Ubiquitin-conjugating enzyme/RWD-like
IPR000608 Ubiquitin-conjugating enzyme, E2
IPR015582 Ubiquitin-conjugating enzyme E2 H10
PDB Chain
ModBase
CATH Domain
SCOP Domain

PublicationsHelp
1. Pickart CM, Fushman D.
Polyubiquitin chains: polymeric protein signals.
8 610-6 2004 [PubMed: 15556404]
http://dx.doi.org/10.1016/j.cbpa.2004.09.009
2. Sun L, Chen ZJ.
The novel functions of ubiquitination in signaling.
Curr. Opin. Cell Biol. 16 119-26 2004 [PubMed: 15196553]
http://dx.doi.org/10.1016/j.ceb.2004.02.005
3. Burger AM, Seth AK.
The ubiquitin-mediated protein degradation pathway in cancer: therapeutic implications.
Eur. J. Cancer 40 2217-29 2004 [PubMed: 15454246]
http://dx.doi.org/10.1016/j.ejca.2004.07.006
4. Passmore LA, Barford D.
Getting into position: the catalytic mechanisms of protein ubiquitylation.
Biochem. J. 379 513-25 2004 [PubMed: 14998368]
http://dx.doi.org/10.1042/BJ20040198
5. Plafker SM, Plafker KS, Weissman AM, Macara IG.
Ubiquitin charging of human class III ubiquitin-conjugating enzymes triggers their nuclear import.
J. Cell Biol. 167 649-59 2004 [PubMed: 15545318]
http://dx.doi.org/10.1083/jcb.200406001

Additional ReadingHelp
Ponting CP, Cai YD, Bork P.
The breast cancer gene product TSG101: a regulator of ubiquitination?
J. Mol. Med. 75 1997 467-9 [PubMed: 9253709]
Jentsch S, Seufert W, Sommer T, Reins HA.
Ubiquitin-conjugating enzymes: novel regulators of eukaryotic cells.
Trends Biochem. Sci. 15 1990 195-8 [PubMed: 2193438]
http://dx.doi.org/10.1016/0968-0004(90)90161-4
Cook WJ, Jeffrey LC, Sullivan ML, Vierstra RD.
Three-dimensional structure of a ubiquitin-conjugating enzyme (E2).
J. Biol. Chem. 267 1992 15116-21 [PubMed: 1321826]
http://intl.jbc.org/cgi/reprint/267/21/15116.pdf
Hershko A.
The ubiquitin pathway for protein degradation.
Trends Biochem. Sci. 16 1991 265-8 [PubMed: 1656558]
http://dx.doi.org/10.1016/0968-0004(91)90101-Z
Mace PD, Linke K, Feltham R, Schumacher FR, Smith CA, Vaux DL, Silke J, Day CL.
Structures of the cIAP2 RING domain reveal conformational changes associated with ubiquitin-conjugating enzyme (E2) recruitment.
J. Biol. Chem. 283 2008 31633-40 [PubMed: 18784070]
http://dx.doi.org/10.1074/jbc.M804753200
Cook WJ, Jeffrey LC, Xu Y, Chau V.
Tertiary structures of class I ubiquitin-conjugating enzymes are highly conserved: crystal structure of yeast Ubc4.
Biochemistry 32 1993 13809-17 [PubMed: 8268156]
http://dx.doi.org/10.1021/bi00213a009
Jentsch S, Seufert W, Hauser HP.
Genetic analysis of the ubiquitin system.
Biochim. Biophys. Acta 1089 1991 127-39 [PubMed: 1647207]
http://dx.doi.org/10.1016/0167-4781(91)90001-3
Vedadi M, Lew J, Artz J, Amani M, Zhao Y, Dong A, Wasney GA, Gao M, Hills T, Brokx S, Qiu W, Sharma S, Diassiti A, Alam Z, Melone M, Mulichak A, Wernimont A, Bray J, Loppnau P, Plotnikova O, Newberry K, Sundararajan E, Houston S, Walker J, Tempel W, Bochkarev A, Kozieradzki I, Edwards A, Arrowsmith C, Roos D, Kain K, Hui R.
Genome-scale protein expression and structural biology of Plasmodium falciparum and related Apicomplexan organisms.
Mol. Biochem. Parasitol. 151 2007 100-10 [PubMed: 17125854]
http://dx.doi.org/10.1016/j.molbiopara.2006.10.011
Koonin EV, Abagyan RA.
TSG101 may be the prototype of a class of dominant negative ubiquitin regulators.
Nat. Genet. 16 1997 330-1 [PubMed: 9241264]
http://dx.doi.org/10.1038/ng0897-330
Cook WJ, Martin PD, Edwards BF, Yamazaki RK, Chau V.
Crystal structure of a class I ubiquitin conjugating enzyme (Ubc7) from Saccharomyces cerevisiae at 2.9 angstroms resolution.
Biochemistry 36 1997 1621-7 [PubMed: 9048545]
http://dx.doi.org/10.1021/bi962639e
Wilson RC, Hughes RC, Flatt JW, Meehan EJ, Ng JD, Twigg PD.
Structure of full-length ubiquitin-conjugating enzyme E2-25K (huntingtin-interacting protein 2).
Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 65 2009 440-4 [PubMed: 19407372]
Knipscheer P, Flotho A, Klug H, Olsen JV, van Dijk WJ, Fish A, Johnson ES, Mann M, Sixma TK, Pichler A.
Ubc9 sumoylation regulates SUMO target discrimination.
Mol. Cell 31 2008 371-82 [PubMed: 18691969]
http://dx.doi.org/10.1016/j.molcel.2008.05.022
Huang DT, Hunt HW, Zhuang M, Ohi MD, Holton JM, Schulman BA.
Basis for a ubiquitin-like protein thioester switch toggling E1-E2 affinity.
Nature 445 2007 394-8 [PubMed: 17220875]
http://dx.doi.org/10.1038/nature05490
spacer
spacer
InterPro 23.1